Variant report
Variant | esv3374043 |
---|---|
Chromosome Location | chr3:163981299-164017775 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs533144948 | chr3:163981333-163981334 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs187435843 | chr3:163981369-163981370 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs375004376 | chr3:163981371-163981372 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs560667669 | chr3:163981404-163981405 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs192615790 | chr3:163981425-163981426 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs549122178 | chr3:163981495-163981496 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs551123113 | chr3:163981509-163981510 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs562754273 | chr3:163981543-163981544 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs1575154 | chr3:163981544-163981545 | Weak transcription Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs551681564 | chr3:163981556-163981557 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs372153758 | chr3:163981564-163981565 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs571136335 | chr3:163981576-163981577 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs533819759 | chr3:163981624-163981625 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs536911229 | chr3:163981646-163981647 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs547167879 | chr3:163981665-163981666 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs571792778 | chr3:163981705-163981706 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs1575155 | chr3:163981709-163981710 | Weak transcription Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs115904595 | chr3:163981731-163981732 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs556353270 | chr3:163981751-163981752 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs74561129 | chr3:163981770-163981771 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs77951820 | chr3:163981771-163981772 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs73031501 | chr3:163981807-163981808 | Weak transcription Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs1853105 | chr3:163981838-163981839 | Weak transcription Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs371643066 | chr3:163981839-163981840 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs572852275 | chr3:163981858-163981859 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs577183560 | chr3:163981883-163981884 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs115453787 | chr3:163981987-163981988 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs540660341 | chr3:163982075-163982076 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs184011644 | chr3:163982084-163982085 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs573759443 | chr3:163982107-163982108 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs542731270 | chr3:163982132-163982133 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs563389005 | chr3:163982190-163982191 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs187763919 | chr3:163982217-163982218 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs531815794 | chr3:163982310-163982311 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs80012984 | chr3:163982358-163982359 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs372473562 | chr3:163982372-163982373 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs565612637 | chr3:163982383-163982384 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs577624497 | chr3:163982391-163982392 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs13068095 | chr3:163982436-163982437 | Weak transcription Strong transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs567160137 | chr3:163982441-163982442 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs536317390 | chr3:163982444-163982445 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs192523148 | chr3:163982480-163982481 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs569843051 | chr3:163982484-163982485 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs538869673 | chr3:163982512-163982513 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs558560401 | chr3:163982520-163982521 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs201231395 | chr3:163982581-163982582 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs548894140 | chr3:163982591-163982592 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs184801358 | chr3:163982597-163982598 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs188411277 | chr3:163982605-163982606 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs147211665 | chr3:163982622-163982623 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malformation | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
epilepsy | 18472482 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Parkinson disease | 21907011 | CNVD |
Bladder cancer | 21909424 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Cancer | 20164919 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21364760 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Alcoholism | 21790672 | CNVD |
Schizophrenia | 20967226 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Acute myeloid leukemia | 19651600 | CNVD |
Autism | 19287141 | CNVD |
Incontinentia Pigmenti | 22033527 | CNVD |
Rett syndrome | 21593744 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Autism | 20531469 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
Glioma | 20126413 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:163963200-163995200 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr3:163979000-163996200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
3 | chr3:163982400-163983200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr3:163990800-163993200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr3:163994400-163995200 | ZNF genes & repeats | HUES6 Cell Line | embryonic stem cell |
6 | chr3:163995200-164000600 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr3:163996200-163997000 | ZNF genes & repeats | ES-I3 Cell Line | embryonic stem cell |
8 | chr3:164000600-164002200 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr3:164002200-164003000 | Genic enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr3:164003000-164005600 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr3:164005600-164006800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr3:164006800-164007200 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr3:164007200-164007600 | Genic enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr3:164007600-164009400 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr3:164009400-164009800 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
16 | chr3:164009400-164009800 | Active TSS | H9 Cell Line | embryonic stem cell |
17 | chr3:164009400-164009800 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
18 | chr3:164009800-164014200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
19 | chr3:164014200-164015400 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
20 | chr3:164015400-164017000 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
21 | chr3:164017000-164017400 | Transcr. at gene 5' and 3' | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
22 | chr3:164017400-164019800 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |